<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Jiang Y</submitter><funding>NCI NIH HHS</funding><pagination>38-53</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5300005</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>7(1)</volume><pubmed_abstract>Somatic mutations in CREBBP occur frequently in B-cell lymphoma. Here, we show that loss of CREBBP facilitates the development of germinal center (GC)-derived lymphomas in mice. In both human and murine lymphomas, CREBBP loss-of-function resulted in focal depletion of enhancer H3K27 acetylation and aberrant transcriptional silencing of genes that regulate B-cell signaling and immune responses, including class II MHC. Mechanistically, CREBBP-regulated enhancers are counter-regulated by the BCL6 transcriptional repressor in a complex with SMRT and HDAC3, which we found to bind extensively to MHC class II loci. HDAC3 loss-of-function rescued repression of these enhancers and corresponding genes, including MHC class II, and more profoundly suppressed CREBBP-mutant lymphomas in vitro and in viv</pubmed_abstract><journal>Cancer discovery</journal><pubmed_title>CREBBP Inactivation Promotes the Development of HDAC3-Dependent Lymphomas.</pubmed_title><pmcid>PMC5300005</pmcid><funding_grant_id>R01 CA164605</funding_grant_id><funding_grant_id>R01 CA187109</funding_grant_id><funding_grant_id>R01 CA190384</funding_grant_id><funding_grant_id>P01 CA023766</funding_grant_id><funding_grant_id>P30 CA008748</funding_grant_id><funding_grant_id>R01 CA183876</funding_grant_id><funding_grant_id>R01 CA194547</funding_grant_id><funding_grant_id>R01 CA178765</funding_grant_id><funding_grant_id>T32 CA009582</funding_grant_id><funding_grant_id>P50 CA192937</funding_grant_id><pubmed_authors>Melnick AM</pubmed_authors><pubmed_authors>Doane AS</pubmed_authors><pubmed_authors>Chu CS</pubmed_authors><pubmed_authors>Ennishi D</pubmed_authors><pubmed_authors>Roeder RG</pubmed_authors><pubmed_authors>McNally D</pubmed_authors><pubmed_authors>Teater M</pubmed_authors><pubmed_authors>Holson E</pubmed_authors><pubmed_authors>Wang L</pubmed_authors><pubmed_authors>Jiang Y</pubmed_authors><pubmed_authors>Ortega-Molina A</pubmed_authors><pubmed_authors>Wang S</pubmed_authors><pubmed_authors>Scott DW</pubmed_authors><pubmed_authors>Gascoyne RD</pubmed_authors><pubmed_authors>Ying HY</pubmed_authors><pubmed_authors>Kranz JE</pubmed_authors><pubmed_authors>Wendel HG</pubmed_authors><pubmed_authors>Sharma S</pubmed_authors><pubmed_authors>Elemento O</pubmed_authors><pubmed_authors>Meydan C</pubmed_authors><pubmed_authors>Agirre X</pubmed_authors><pubmed_authors>Li Z</pubmed_authors><pubmed_authors>Geng H</pubmed_authors><pubmed_authors>Young JW</pubmed_authors><pubmed_authors>Parsa S</pubmed_authors><pubmed_authors>Hatzi K</pubmed_authors><pubmed_authors>Stengel KR</pubmed_authors><pubmed_authors>Tam W</pubmed_authors><pubmed_authors>Poloway D</pubmed_authors><pubmed_authors>Shaknovich R</pubmed_authors><pubmed_authors>Hiebert SW</pubmed_authors></additional><is_claimable>false</is_claimable><name>CREBBP Inactivation Promotes the Development of HDAC3-Dependent Lymphomas.</name><description>Somatic mutations in CREBBP occur frequently in B-cell lymphoma. Here, we show that loss of CREBBP facilitates the development of germinal center (GC)-derived lymphomas in mice. In both human and murine lymphomas, CREBBP loss-of-function resulted in focal depletion of enhancer H3K27 acetylation and aberrant transcriptional silencing of genes that regulate B-cell signaling and immune responses, including class II MHC. Mechanistically, CREBBP-regulated enhancers are counter-regulated by the BCL6 transcriptional repressor in a complex with SMRT and HDAC3, which we found to bind extensively to MHC class II loci. HDAC3 loss-of-function rescued repression of these enhancers and corresponding genes, including MHC class II, and more profoundly suppressed CREBBP-mutant lymphomas in vitro and in viv</description><dates><release>2017-01-01T00:00:00Z</release><publication>2017 Jan</publication><modification>2026-04-17T15:23:39.501Z</modification><creation>2019-03-27T02:36:11Z</creation></dates><accession>S-EPMC5300005</accession><cross_references><pubmed>27733359</pubmed><doi>10.1158/2159-8290.CD-16-0975</doi><doi>10.1158/2159-8290.cd-16-0975</doi></cross_references></HashMap>